Whistle-Blowers' Experiences in Fraud Litigation against Pharmaceutical Companies
Aaron S Kesselheim, David M Studdert, Michelle M Mello
New England Journal of Medicine | MASSACHUSETTS MEDICAL SOC | Published : 2010
Awarded by Agency for Healthcare Research and Quality
Supported by a career development award (K08HS18465-01) from the Agency for Healthcare Research and Quality (to Dr. Kesselheim), a Federation Fellowship from the Australian Research Council (to Dr. Studdert), and funding from the Greenwall Faculty Scholars Program in Bioethics (to Dr. Mello). The study was approved by ethics review boards at Brigham and Women's Hospital and the Harvard School of Public Health.